Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copanlisib and Cetuximab in R/M HNSCC
NCT02822482Phase 2Terminated
- Sponsor
- Unicancer
- Start
- Jun 2016
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
A Phase 2 trial of copanlisib in head and neck squamous cell carcinoma (HNSCC), sponsored by Unicancer. Started Jun 2016; status: terminated.
02
Drugs
copanlisib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02822482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02822482.